Search research articles
Contact Us
Filters
Showing results (111-120 of 273) with videos related to
Page
of 28
Sort By:
Haematologica
|
June 1, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Jennifer L Crombie, Caron A Jacobson, Robert Redd, et al.
Blood
|
September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Philippe Armand, Ann Janssens, Giuseppe Gritti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 4, 2015
Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation
Brandon K C Au, Ted A Gooley, Philippe Armand, et al.
Leukemia & Lymphoma
|
December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant
Andrew A Lane, Philippe Armand, Yang Feng, et al.
Blood
|
September 9, 2008
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
Corey Cutler, Kristen Stevenson, Haesook T Kim, et al.
Science Translational Medicine
|
April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease
Ken-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease
Alex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood Advances
|
June 23, 2026
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL
Jennifer L Crombie, Inhye E Ahn, Yue Ren, et al.
Leukemia & Lymphoma
|
January 7, 2020
Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis
Pier Luigi Zinzani, Robert Chen, Philippe Armand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia
Philip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 273) with videos related to
Sort By:
Page
of 28
Haematologica
|
June 1, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy
Jennifer L Crombie, Caron A Jacobson, Robert Redd, et al.
Blood
|
September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Philippe Armand, Ann Janssens, Giuseppe Gritti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 4, 2015
Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation
Brandon K C Au, Ted A Gooley, Philippe Armand, et al.
Leukemia & Lymphoma
|
December 3, 2011
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant
Andrew A Lane, Philippe Armand, Yang Feng, et al.
Blood
|
September 9, 2008
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
Corey Cutler, Kristen Stevenson, Haesook T Kim, et al.
Science Translational Medicine
|
April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease
Ken-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease
Alex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Blood Advances
|
June 23, 2026
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL
Jennifer L Crombie, Inhye E Ahn, Yue Ren, et al.
Leukemia & Lymphoma
|
January 7, 2020
Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis
Pier Luigi Zinzani, Robert Chen, Philippe Armand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia
Philip C Amrein, Eyal C Attar, Tak Takvorian, et al.
Page
of 28